AnilPottiMD

Oncology • Grand Forks, ND

Hematologic Oncology, Thoracic Cancer

Physician

Join to view full profile

Dr. Potti is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Potti's full profile

Already have an account?

Office
1451 44th Ave S
Ste E
Grand Forks, ND 58201
Phone+1 701-787-5800

Fax+1 701-787-5802
Is this information wrong?

Education & Training

Duke University HospitalFellowship, Hematology and Medical Oncology, 2003 - 2006
University of North DakotaResidency, Internal Medicine, 1996 - 2000
Christian Medical College VelloreClass of 1995

Certifications & Licensure

ND State Medical License 2012 - 2024
MN State Medical License 2012 - 2024
SC State Medical License 2011 - 2017
NC State Medical License 2003 - 2015
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

19 citations
Clinical course of lung cancer in patients with chronic kidney disease.
Purvi Patel, Lisa L Henry, Apar Kishor Ganti, Anil Potti> ;Lung Cancer. 2004 Mar 1
3 citations
Potassium homeostasis in patients receiving prophylactic dose enoxaparin therapy.
Anil Potti, B. Danielson, R. Badreddine, Thomas L. Ortel> ;Journal of Thrombosis and Haemostasis. 2004 Jul 1
19 citations
Tyrosine Kinase Inhibitors in Renal Cell Carcinoma
Anil Potti, Daniel J. George> ;Clinical Cancer Research. 2004 Sep 15
3 citations
Regulatable aptamers in medicine: focus on antithrombotic strategies.
Anil Potti, Christopher P. Rusconi, Bruce A. Sullenger, Thomas L. Ortel> ;Expert Opinion on Biological Therapy. 2004 Oct 1
43 citations
Anaerobic spondylodiscitis: case series and systematic review.
Musab U. Saeed, Paul Mariani, Candelaria Martin, Raymond A. Smego, Anil Potti, Robert Tight, David Thiege> ;Southern Medical Journal. 2005 Feb 1
2 citations
Thrombophilia and thrombosis in thrombotic thrombocytopenic purpura.
Anil Potti, Veshana Ramiah, Thomas L. Ortel> ;Seminars in Thrombosis and Hemostasis. 2005 Dec 1
5 citations
Genomic signatures in non-small-cell lung cancer: targeting the targeted therapies.
Holly K. Dressman, Andrea H. Bild, Jennifer Garst, David H. Harpole, Anil Potti> ;Current Oncology Reports. 2006 Jul 1
55 citations
A genomic approach to identify molecular pathways associated with chemotherapy resistance
Richard F. Riedel, Alessandro Porrello, Emily Pontzer, Emily J. Chenette, David S. Hsu, Bala S. Balakumaran, Anil Potti, Joseph R. Nevins, Phillip G. Febbo> ;Molecular Cancer Therapeutics. 2008 Oct 1
76 citations
A Genomic Strategy to Elucidate Modules of Oncogenic Pathway Signaling Networks
Jeffrey T. Chang, Carlos M. Carvalho, Seiichi Mori, Andrea H. Bild, Michael L. Gatza, Quanli Wang, Joseph E. Lucas, Anil Potti, Phillip G. Febbo, Mike West, Joseph R. ...> ;Molecular Cell. 2009 Apr 10
10 citations
Characterizing the Clinical Relevance of an Embryonic Stem Cell Phenotype in Lung Adenocarcinoma
Marvaretta Stevenson, William Mostertz, Chaitanya R. Acharya, William Kim, Kelli S. Walters, William T. Barry, Kristin Higgins, Sascha A. Tuchman, Jeffrey Crawford, Go...> ;Clinical Cancer Research. 2009 Dec 15
46 citations
Age- and sex-specific genomic profiles in non-small cell lung cancer.
William Mostertz, Marvaretta Stevenson, Chaitanya R. Acharya, Isaac S. Chan, Kelli S. Walters, Wisut Lamlertthon, William T. Barry, Jeffrey Crawford, Joseph R. Nevins,...> ;JAMA. 2010 Feb 10
3 citations
Retraction in part: A genomic approach to identify molecular pathways associated with chemotherapy resistance.
Richard F. Riedel, Alessandro Porrello, Emily Pontzer, Emily J. Chenette, David S. Hsu, Bala S. Balakumaran, Anil Potti, Joseph R. Nevins, Phillip Febbo> ;Molecular Cancer Therapeutics. 2012 Mar 29
Retraction: Characterizing the Clinical Relevance of an Embryonic Stem Cell Phenotype in Lung Adenocarcinoma
Marvaretta Stevenson, William Mostertz, Chaitanya R. Acharya, William Kim, Kelli S. Walters, William T. Barry, Kristin Higgins, Sascha A. Tuchman, Jeffrey Crawford, Go...> ;Clinical Cancer Research. 2012 Mar 15
3 citations
An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer (Journal of Clinical Oncology (2007) 25 (517-525))
Holly K. Dressman, Andrew Berchuck, Gina Chan, Jun Zhai, Andrea H. Bild, Robyn Sayer, Janiel M. Cragun, Jennifer Clarke, Regina S. Whitaker, Li Hua Li, Jonathan Gray, ...> ;Journal of Clinical Oncology. 2012 Feb 20
1 citations
Retraction: Acharya CR, et al. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer. JAMA. 2008;299(13):1574-1587
Chaitanya R. Acharya, David S. Hsu, Carey K. Anders, Ariel Anguiano, Kelly H. Salter, Kelli S. Walters, Richard C. Redman, Sascha A. Tuchman, Cynthia A. Moylan, Sayan ...> ;JAMA. 2012 Feb 1
A Pathway-Based Approach to Identify Molecular Biomarkers in Cancer
Marvaretta Stevenson, Anil Potti> ;Annals of Surgical Oncology. 2012 Jul 1
4 citations
Gene-expression patterns predict phenotypes of immune-mediated thrombosis (Blood (2006) 107, 4, (1391-1396))
Anil Potti, Andrea Bild, Holly K. Dressman, Deborah A. Lewis, Joseph R. Nevins, Thomas L. Ortel> ;Blood. 2011 Oct 20
5 citations
Retraction for Garman et al: A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunities.
Katherine S. Garman, Chaitanya R. Acharya, Elena Edelman, Marian Grade, Jochen Gaedcke, Shivani Sud, William T. Barry, Anna Mae Diehl, Dawn Provenzale, Geoffrey S. Gin...> ;Proceedings of the National Academy of Sciences of the United States of America. 2011 Oct 18
24 citations
Retraction: A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med 2006;355:570-80.
Anil Potti, Sayan Mukherjee, Rebecca P. Petersen, Holly K. Dressman, Andrea H. Bild, Jason I. Koontz, Robert A. Kratzke, Mark A. Watson, Michael J. Kelley, Geoffrey S....> ;The New England Journal of Medicine. 2011 Mar 23
29 citations
Retraction: Genomic signatures to guide the use of chemotherapeutics
Anil Potti, Holly K. Dressman, Andrea H. Bild, Richard F. Riedel, Gina Chan, Robyn Sayer, Janiel M. Cragun, Hope Cottrill, Michael J. Kelley, Rebecca P. Petersen, Davi...> ;Nature Medicine. 2011 Jan 1
7 citations
Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer (Journal of Clinical Oncology (2007) 25, (...
David S. Hsu, Bala S. Balakumaran, Chaitanya R. Acharya, Vanja Vlahovic, Kelli S. Walters, Katherine S. Garman, Carey K. Anders, Richard F. Riedel, Johnathan M. Lancas...> ;Journal of Clinical Oncology. 2010 Dec 10
62 citations
The lung cancer exercise training study: a randomized trial of aerobic training, resistance training, or both in postsurgical lung cancer patients: rationale and design
Lee W. Jones, Neil D. Eves, William E. Kraus, Anil Potti, Jeffrey Crawford, James A. Blumenthal, Bercedis L. Peterson, Pamela S. Douglas> ;BMC Cancer. 2010 Apr 21
24 citations
Refocusing the War on Cancer: The Critical Role of Personalized Treatment
Anil Potti, Richard L. Schilsky, Joseph R. Nevins> ;Science Translational Medicine. 2010 Apr 21
250 citations
A pathway-based classification of human breast cancer
Michael L. Gatza, Joseph E. Lucas, William T. Barry, Jong Wook Kim, Quanli Wang, Matthew D. Crawford, Michael B. Datto, Michael J. Kelley, Bernard Mathey-Prevot, Anil ...> ;Proceedings of the National Academy of Sciences of the United States of America. 2010 Apr 13
29 citations
A Genomic Approach to Improve Prognosis and Predict Therapeutic Response in Chronic Lymphocytic Leukemia
Daphne R. Friedman, J. Brice Weinberg, William T. Barry, Barbara K. Goodman, Alicia D. Volkheimer, Karen M. Bond, Youwei Chen, Ning Jiang, Joseph O. Moore, Jon P. Gock...> ;Clinical Cancer Research. 2009 Nov 15
Join now to see all